| Time | Topic | Faculty Speaker | Moderator |
| 08:00 – 08:30 | Registration |
| 08:30 – 08:35 | Welcome Remarks | Dr. Koichi Akashi |
| 08:35 – 08:40 | Opening Remarks | Dr. Norio Komatsu |
| Basic Science of MPN |
| 08:40 – 09:15 | Mutations in MPN: Hereditary Predispositions, Disease Initiators and Drivers of Progression | Dr. Robert Kralovics | Dr. Norio Komatsu Dr. Robert Kralovics |
| 09:15 – 09:40 | The Role of Wild and Mutant Calreticulin in Hematopoiesis | Dr. Kazuya Shimoda |
| 09:40 – 10:05 | Molecular Mechanisms Leading to the Development of Myeloproliferative Neoplasms by Mutant Calreticulin | Dr. Marito Araki |
| 10:05 – 10:25 | The role of HMGA2 in MPN | Dr. Chih-Cheng Chen |
| MPN Pathology |
| 10:25 – 11:05 | New WHO Classification of Myeloproliferative Neoplasms | Dr. Hans-Michael Kvasnicka | Dr. Masafumi Ito |
| 11:05 – 12:00 | Lunch |
| Hot Topic of MPN |
| 12:00 – 12:35 | MPN Disease Burden: Lessons Learned from Patients | Dr. Ruben Mesa | Dr. Yuzuru Kanakura |
| Asian MPN Session |
| 12:35 – 12:55 | Childhood Myeloproliferative Neoplasms | Dr. Jong Jin Seo | Dr. Keita Kirito Dr. Dong-Tsamn Lin |
| 12:55 – 13:15 | Clinical Outcomes of Patients with Primary Myelofibrosis in Japan: A Report of a Nationwide Survey from 1999 to 2015 | Dr. Katsuto Takenaka |
| 13:15 – 13:35 | Primary Myelofibrosis in Taiwan | Dr. Lee-Yung Shih |
| 13:35 – 13:55 | Chronic Neutrophilic Leukemia: Experience from China | Dr. Qian Jiang |
| 13:55 – 14:15 | Coffee Break |
| IFN Renaissance |
| 14:15 – 14:40 | IFN Treatment for PV | Dr. Richard Silver | Dr. Jean-Jacques Kiladjian Dr. Srdan Verstovsek |
| 14:40 – 15:00 | Long Term Results of Peg-IFN Therapy in PV and ET | Dr. Srdan Verstovsek |
| 15:00– 15:20 | Results of the PROUD-PV Study | Dr. Heinz Gisslinger |
| 15:20 – 15:40 | Molecular Landscape of MPN: Influence on Response to Therapy and Evolution Under Treatment with Interferon Alpha | Dr. Bruno Cassinat |
| 15:40 – 16:00 | Can We Alter MPN Evolution with IFN Therapy? | Dr. Jean-Jacques Kiladjian |
| 16:00 – 16:20 | New Antiviral Mechanism of Interferon on Hepatitis B virus | Dr. Pei-Jer Chen |
| Panel Discussion |
| 16:20 – 16:45 | Chair: Dr. Jean-Jacques Kiladjian & Dr. Srdan Verstovsek |
| 16:45 – 16:50 | Closing Remarks | Dr. Kazuya Shimoda |